A Long-term Extension of Study GNC-401

Clinical trial NCT05049161 · TERMINATED

Trial details

NCT number: NCT05049161
Sponsor: GeNeuro Innovation SAS
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2021-08-27
Primary completion: 2022-05-18
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.